Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Iloprost and Eptifibatide Co-administration Compared to Standard Therapy in Patients With Septic Shock - a Randomized, Controlled, Double-blind Investigator-initiated Trial

NCT02204852 is registered in ClinicalTrials.gov with Sisse R. Ostrowski, MD PhD DMSc as lead sponsor.

NCT NCT02204852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02204852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Iloprost and Eptifibatide Co-administration Compared to Standard Therapy in Patients With Septic Shock - a Randomized, Controlled, Double-blind Investigator-initiated Trial
Lead sponsor
Sisse R. Ostrowski, MD PhD DMSc
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
August 31, 2016
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock